CARDIOL THERAPEUTICS INC-A (CRDL) Institutional Ownership Changes & 13F Activity

CARDIOL THERAPEUTICS INC-A (CRDL) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCBuy219,706229,806$310,238
Q1 2023Renaissance Technologies LLCSell-82,90010,100$5
Q4 2021Renaissance Technologies LLCSell-51,90093,000$171
Q3 2021Renaissance Technologies LLCBuy144,900144,900$598

Frequently asked questions about CRDL activity

  • Which institutional owners are buying CRDL?

    Institutional owners buying CRDL include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in CRDL activity?

    "Buy" means an investor increased their reported position in CRDL compared to the prior reporting period. This reflects growing exposure to CARDIOL THERAPEUTICS INC-A (CRDL) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in CRDL increasing?

    Institutional interest in CRDL can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related CRDL insights